Paweł Domagała

University of Zielona Góra

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Cancer Biology Cancer Biology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (9)

piotr kozlowski

Institute of Bioorganic Chemistry Polish Academy of Sciences

POLAND

View details

Stefan Oswald

GERMANY

View details

Sylwia Szeląg-Pieniek

Pomeranian Medical University

POLAND

View details

Joanna Łapczuk-Romańska

Pomeranian Medical University

POLAND

View details

Malwina Suszynska

Institute of Bioorganic Chemistry Polish Academy of Sciences

POLAND

View details

Cezary Cybulski

Pomeranian Medical University

POLAND

View details

Jakub Rosik

Pomeranian Medical University

POLAND

View details

Jan Lubiński

Pomeranian Medical University

POLAND

View details

Mariusz Naczk

Head of Institute of Health Sciences/Professor

University of Zielona Góra

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paweł Domagała

Research Interests

Explore related searches

Contact this professor

Articles (9)

Nuclear expression of Ku70/80 is associated with CHEK2 germline mutations in breast cancer

Variants in ATRIP are associated with breast cancer susceptibility in the Polish population and UK Biobank.

Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?

PALB2 mutations and prostate cancer risk and survival.

Monocarboxylate Transporter 1 (MCT1) in Liver Pathology

Constitutional variants in POT1, TERF2IP, and ACD genes in patients with melanoma in the Polish population.

Colorectal Adenocarcinomas Harboring ALK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 12 Cases and Review of the Literature.

Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland.

Nuclear CK19-immunopositive pseudoinclusions as a new additional objective diagnostic feature of papillary thyroid carcinoma.

Collaborators (9)

piotr kozlowski

Stefan Oswald

Sylwia Szeląg-Pieniek

Joanna Łapczuk-Romańska

Malwina Suszynska

Cezary Cybulski

Jakub Rosik

Jan Lubiński

Mariusz Naczk

Make your next move.